Noted: But if Aprecia does manage to move the drug-manufacturing process closer to the patient, it will buck more than a general trend toward centralization and mass production. Drug manufacturers have tended to consolidate not only over the past 100 years but also over the past couple decades, says Gregory Higby, a University of Wisconsin professor and the executive director of the American Institute of the History of Pharmacy. This corporate consolidation especially accelerated during the 1990s, he told me.
Office of Strategic Communication